LTBR and Neonatal respiratory distress: Notably, Etanercept[28] and Asciminib hydrochloride,[29] which function as LTBR gene activators and maintain normal LTBR gene expression, emerge as promising therapeutic candidates for neonatal respiratory distress through their LTBR activation mechanism.